Orphan Drugs Market By Drug Type (Biological and Non- Biological), By Top Selling Drugs (Revlimid, Rituxan, Copaxone, Opdivo, Keytruda, Imbruvica, Avonex, Sensipar, Soliris, and Other Top Selling Drugs), By Disease Type (Oncology, Hematology, Neurology, Cardiovascular, and Other Disease Types), By Phase (Phase I, Phase II, Phase III, and Phase IV), and By Region - Trends, Analysis and Forecast till 2030

Report Code: PMI379319 | Publish Date: August 2023 | No. of Pages: 168

Global Orphan Drugs Market Market Companies

  • AbbVie Inc.
  • Celgene Corporation
  • Biogen
  • Teva Pharmaceutical Industries
  • F. Hoffmann-La Roche AG
  • Bristol-Myers Squibb Company
  • Alexion Pharmaceuticals
  • Amgen
  • Merck & Co. Inc.

Recent News:

  • In March 2022, CER-001, evolved through ABIONYX Pharma, obtained FDA Orphan Drugs Designation (ODD) for the analysis of LCAT deficiency manifesting as kidney disorder and/or ophthalmologic illness.
  • In November 2021, Emmes` revel in may be mixed with that of Orphan Reach, a UK-primarily based totally strong point CRO that Emmes obtained in May 2021. Emmes' world-elegance biostatistics, statistics management, and medical trial execution competencies will permit the middle to characteristic as a full-service, stop-to-stop offerings organization.